$1.24 Billion is the total value of Vident Investment Advisory, LLC's 685 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMCL | New | OMNICELL INC | $13,684,000 | – | 159,055 | +100.0% | 1.10% | – |
| ZIOP | New | ZIOPHARM ONCOLOGY INC | $1,624,000 | – | 278,609 | +100.0% | 0.13% | – |
| ZYME | New | ZYMEWORKS INC | $1,563,000 | – | 71,026 | +100.0% | 0.13% | – |
| DTIL | New | PRECISION BIOSCIENCES INC | $1,550,000 | – | 116,951 | +100.0% | 0.12% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,546,000 | – | 32,833 | +100.0% | 0.12% | – |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $1,456,000 | – | 90,425 | +100.0% | 0.12% | – |
| EEFT | New | EURONET WORLDWIDE INC | $617,000 | – | 3,669 | +100.0% | 0.05% | – |
| ACIW | New | ACI WORLDWIDE INC | $587,000 | – | 17,098 | +100.0% | 0.05% | – |
| WAT | New | WATERS CORP | $460,000 | – | 2,135 | +100.0% | 0.04% | – |
| KEY | New | KEYCORP NEW | $438,000 | – | 24,653 | +100.0% | 0.04% | – |
| COO | New | COOPER COS INC | $437,000 | – | 1,298 | +100.0% | 0.04% | – |
| BR | New | BROADRIDGE FINL SOLUTIONS IN | $436,000 | – | 3,416 | +100.0% | 0.04% | – |
| ACN | New | ACCENTURE PLC IRELAND | $348,000 | – | 1,883 | +100.0% | 0.03% | – |
| FDS | New | FACTSET RESH SYS INC | $338,000 | – | 1,178 | +100.0% | 0.03% | – |
| IR | New | INGERSOLL-RAND PLC | $341,000 | – | 2,694 | +100.0% | 0.03% | – |
| ROKU | New | ROKU INC | $330,000 | – | 3,642 | +100.0% | 0.03% | – |
| SERV | New | SERVICEMASTER GLOBAL HLDGS I | $319,000 | – | 6,117 | +100.0% | 0.03% | – |
| ZTS | New | ZOETIS INCcl a | $321,000 | – | 2,832 | +100.0% | 0.03% | – |
| HOLX | New | HOLOGIC INC | $312,000 | – | 6,504 | +100.0% | 0.02% | – |
| DISCK | New | DISCOVERY INC | $257,000 | – | 9,041 | +100.0% | 0.02% | – |
| RNR | New | RENAISSANCERE HOLDINGS LTD | $211,000 | – | 1,186 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NVIDIA CORPORATION | 35 | Q2 2023 | 1.8% |
| UNITEDHEALTH GROUP INC | 35 | Q2 2023 | 1.0% |
| MICROSOFT CORP | 35 | Q2 2023 | 1.2% |
| ELEVANCE HEALTH INC | 35 | Q2 2023 | 0.6% |
| AMGEN INC | 35 | Q2 2023 | 0.7% |
| AT&T INC | 35 | Q2 2023 | 0.7% |
| WAL-MART STORES INC | 35 | Q2 2023 | 0.8% |
| MERCK & CO INC NEW | 35 | Q2 2023 | 1.0% |
| BRISTOL-MYERS SQUIBB CO | 35 | Q2 2023 | 0.4% |
| QUEST DIAGNOSTICS INC | 35 | Q2 2023 | 0.4% |
View Vident Investment Advisory, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 40-APP | 2021-11-10 |
View Vident Investment Advisory, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.